Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study

• Mhairi Maskew ,

  * E-mail: mmaskew@heroza.org

  Affiliation Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Matthew P. Fox,

  Affiliations Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America, Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Gilles van Cutsem,

  Affiliations Médecins Sans Frontières, Cape Town, South Africa, Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa

  ⨯
• Kathryn Chu,

  Affiliation South Africa Medical Unit (SAMU), Médecins Sans Frontières, Johannesburg, South Africa

  ⨯
• Patrick MacPhail,

  Affiliation Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Andrew Boulle,

  Affiliation Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa

  ⨯
• Matthias Egger,

  Affiliation Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland

  ⨯
• for IeDEA Southern Africa